{
    "Trade/Device Name(s)": [
        "Afinion\u2122 AS100 Analyzer",
        "Afinion\u2122 Data Connectivity Converter (ADCC)",
        "Afinion\u2122 Test Cartridges",
        "Afinion\u2122 Controls",
        "Afinion\u2122 HbA1c",
        "Afinion\u2122 HbA1c Controls",
        "Afinion\u2122 ACR",
        "Afinion\u2122 ACR Control"
    ],
    "Submitter Information": "Axis-Shield PoC AS",
    "510(k) Number": "K110056",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050574",
        "K072409"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JQT",
        "JJX",
        "JR",
        "JFY",
        "JY",
        "DCK"
    ],
    "Summary Letter Date": "January 6, 2011",
    "Summary Letter Received Date": "January 10, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR \u00a7864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (HbA1c)",
        "Albumin",
        "Creatinine",
        "Albumin/creatinine ratio"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Afinion\u2122 AS100 Analyzer",
        "Afinion\u2122 Data Connectivity Converter (ADCC)"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative assay",
        "Data transfer via HL7/ASTM protocol"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Accessory",
        "Test",
        "Control",
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Afinion AS100 Analyzer with Data Connectivity Converter for quantitative measurement of HbA1c in blood and albumin/creatinine ratio in urine at point-of-care",
    "Indications for Use Summary": "Quantitative measurement of HbA1c in whole blood and albumin, creatinine, and albumin/creatinine ratio in urine for diabetes monitoring and nephropathy diagnosis, with automatic data transfer to laboratory information systems",
    "fda_folder": "Hematology"
}